Our Medical Director
Dr. Joel Singer, a board certified plastic surgeon, leverages over 30 years of extensive medical experience in his practices in New York City and Long Island. Possessing a particular interest in nonsurgical and minimally invasive procedures, Dr. Joel Singer incorporates the latest techniques into his repertoire of services. Park Avenue Stem Cell is devoted to clinical research advancing access and quality care in the area of adult stem cell regenerative medicine in order to help people suffering from a variety of inflammatory and degenerative conditions.
He has built a physician network of multiple specialists who have been collaborating with Park Avenue Stem Cell to help treat chronic conditions in their patients. Dr. Singer is passionate about his research into the clinical applications of Stem Cells and has helped numerous people to be free of pain and chronic symptoms. Dr. Joel Singer lectured at international conferences, and has traveled around the globe to provide training to local plastic surgeons, as well as free surgeries to children in need. Dr. Joel Singer continues his involvement in the medical community through active participation in various medical organizations at both national and local levels, including the American Society of Plastic Surgeons and the New England Society of Plastic Surgeons.
Learn more about Park Avenue Stem Cell via our extensive FAQ Page.
To advance cell technology in order to improve the body’s ability to regenerate. Park Avenue Stem Cell Therapy Center is devoted to advancing access and quality care in the area of adult stem cell regenerative medicine in order to help people suffering from a variety of inflammatory and degenerative conditions.
In 2011, Dr. Mark Berman brought back vital technology from Asia that allowed us to isolate SVF stromal vascular fraction which contains high numbers of regenerative cells using a person’s own fat as part of a minor closed surgical procedure. Later that year, Dr. Singer teamed up with Dr. Berman to identify methods to explore the potential therapeutic benefits of SVF.
Dr. Singer continued to improve the process and then formed Park Avenue Stem Cell Treatment Center, a multi-specialty team that could deploy SVF to patients under an institutional review board that governs investigational work on humans. ( See ICSS-2016-001 through 021). The main focus of the research was to establish the safety of autologous use of SVF for various degenerative conditions. This pioneering work spread rapidly because the doctors believed that it was vital to teach the technology to qualified physicians who wanted to bring regenerative medicine into their own practices.
Park Avenue Stem Cell Therapy Center was founded in 2015 to help accomplish this goal. Affiliate physician members of the research group are made up of teams of multidisciplinary specially trained physicians in order to best assess and provide care for their patients. Park Avenue Stem Cell Treatment Center emphasizes quality and is highly committed to clinical research and the advancement of regenerative medicine.
Currently, all Network members are highly qualified and credentialed physicians who use the same sterile closed surgical procedure to process fat from a mini-liposuction procedure in order to isolate and implant a patient’s own source of regenerative cells on the same day. The regenerative cells are found in the SVF stromal vascular fraction which contains a mononuclear cell line (predominantly 2 types of autologous mesenchymal stem cells), macrophage cells, endothelial cells, immune regulatory cells, red blood cells, and important growth factors that facilitate the stem cell processes and promote their activity.
Our technology allows us to isolate high numbers of viable cells that we can deploy during the same surgical setting and specific deployment methods have been developed that are original and unique for each condition being treated. While vigilant about patient safety, we are also learning about which diseases respond best and which deployment methods are most effective. Our Medical Director of Clinical Research, Tobias Moeller-Bertram MD, PhD., and our support team coordinate the collection of data from our affiliate centers all over the world to make the Park Avenue Stem Cell Network is the world’s largest regenerative medicine clinical research organization.
Affiliate network physicians have the opportunity to share not only their data, but their vital clinical experiences thus helping each other to achieve higher levels of scientific understanding and optimizing medical care.
Cells On Ice in collaboration with their technology partner American CryoStem has been established to provide state of the art cryobanking to any patient having a liposuction for either therapeutic (SVF deployment for IRB approved conditions) or cosmetic reasons. A small volume of fat can be preserved as stromal Vascular Fraction (or as expanded stem cells in the near future) and it will remain frozen indefinitely in an FDA registered facility. This enables a person to receive their own autologous stem cells back for future deployments at any time in the future should the medical need arise. Other patients may want to use their own cells in the near future as part of a sequential repeat treatment for various conditions where one treatment is inadequate. Many patients will want to have cells available on a moment’s notice if they had an accident or stroke or heart attack. Some of these cells could even be used for cancer therapies or age mitigation strategies (“Cell Renewal Therapy”). The cost of this “Bio-Insurance” is $2500 to process and then $240 per year to maintain the bank of stem cells. Having your own personal stem cells available for medical immediate use at any time in your life is a valuable medical asset. For more information, call 1-844-903-PARK (7275).
“The Cell Surgical Network and its affiliate treatment centers are not offering stem cell therapy as a cure for any condition, disease, or injury. No statements or implied treatments on this website have been evaluated or approved by the FDA. This website contains no medical advice. All statements and opinions provided by this website are provided for educational and informational purposes only and we do not diagnose or treat via this website or via telephone. The Cell Surgical Network and its affiliate treatment centers are offering patient funded research to provide individual patients with Stromal Vascular Fraction that contains their own autologous stem cells and growth factors and the treatment centers provide surgical procedures only and are not involved in the use or manufacture of any investigational drugs.
The Cell Surgical network does not claim that any applications, or potential applications, using autologous stem cells are approved by the FDA, or are even effective. We do not claim that these treatments work for any listed nor unlisted condition, intended or implied. It’s important for potential patients to do their own research based on the options that we present so that one can make an informed decision. Any decision to participate in our patient funded experimental protocols is completely voluntary.
ATTENTION: If you have ANY concern with stromal vascular fraction, any of our products, methods, website, or technique and think we may be violating any U.S. law, please contact us so that we can investigate the matter or concern immediately.
**Results of these treatments vary from individual to individual and it is not possible to predict or guarantee the outcome of any medical procedure.